Skip to content

Dual-Lumen Balloon Assisted Onyx Embolization of Middle Meningeal Artery for Chronic Subdural Hematoma.

Oct 2026 · AJNR. American journal of neuroradiology · 0 citations
Medicine

Abstract

Background

AND

Purpose

Middle meningeal artery embolization (MMAE) with liquid embolic agents (LEAs) is increasingly used to manage chronic subdural hematoma (CSDH). Conventional microcatheters require distal wedge positioning of the microcatheter tip or proximal plug formation to prevent reflux and achieve effective distal penetration. Dual-lumen balloon microcatheters limit reflux and enable controlled LEA injection, which may improve procedural efficiency. The evidence base for dual-lumen balloons in CSDH is limited.

Materials And Methods

This single-center retrospective study included consecutive adults with CSDH treated from December 2021 to September 2025. The Scepter XC dual-lumen balloon microcatheter was used to arrest antegrade flow and control Onyx-18 delivery, first distal to the anterior branch origin and then from the MMA trunk into the posterior branch. Outcomes included >50% hematoma thickness reduction and complete resolution on computed tomography (CT), recurrence, retreatment, complications, hospital stay, and procedure time.

Results

152 patients were identified; 33 (21.7%) underwent concomitant surgery and 108 (71.1%) standalone MMAE. Median follow-up was 3 months. This technique achieved >50% hematoma thickness reduction in 90.4% and complete resolution in 70.6% at 3 months or last follow-up. There were no serious adverse events definitely associated with the dual-lumen balloon technique. Overall postprocedural complications occurred in 4 patients (2.6%): transient facial palsy in 2 (1.3%), transient diplopia in 1 (0.7%), and bilateral watershed territory cerebral infarctions without long-term neurological deficits in 1 (0.7%). Median hospital stay was 2 days (IQR 1-4), and median procedure duration was 31.5 minutes (IQR 24.3-48.8). None of the patients who completed follow-up experienced CSDH recurrence or required retreatment.

Conclusions

Scepter XC-assisted Onyx-18 MMAE was technically feasible and associated with high rates of CSDH resorption and resolution, with a safety profile similar to other MMAE techniques and no serious adverse events directly attributable to dual-lumen balloon microcatheter use.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.